B Lymphoblastic Leukemia/Lymphoma — Trials

B Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 102
Ph III recruiting: 11
Growth YoY: +17.2%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 43.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (49)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03825718	A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL	completed	Early Phase 1	29	Hebei Yanda Ludaopei HospitalOTHER	1	Apr 28, 2022	clinicaltrials

Data updated 22 days agoSource updated Apr 28, 2022source: clinicaltrials